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INTRODUCTION
Acrodermatitis continua of Hallopeau (ACH), a 
variant of pustular psoriasis, chiefly affects distal parts 
of the hands and feet (1,2). Arthritis occasionally oc-
curs in psoriasis, including pustular psoriasis, as pso-
riatic arthritis (3), but it is uncommon in ACH. Here, 
we report on two cases of ACH with arthritis that was 
improved by infliximab together with methotrexate 
as well as salazosulfapyridine. As arthritis is refractory 
to conventional therapies, our cases could provide a 
clue to clarifying therapies for ACH.
CASE REPORTS
Case 1
A 29-year-old man visited our hospital with polyar-
thralgia chiefly at the fingers and big toes. Four years 
previously, he found cloudy alterations in the nail of 
the left middle finger. Two years later, distal interpha-
langeal joints of the bilateral hands became swollen, 
reddish and painful, together with pustular forma-
tion under the nail plate. The nails became deformed 
and discolored gradually. Reddish eruptions had not 
appeared over the trunk and extremities except for 
acral regions. On the first visit, distal interphalangeal 
joints of the hands and metatarsophalangeal joints of 
the big toes were swollen left to right asymmetrically, 
together with onycholysis and subungual hyperkera-
tosis (Fig. 1a). Erythematous changes were diffusely 
distributed on peripheral regions of the fingers and 
toes. Routine hematologic and immunologic exami-
nations were normal. Bone x-rays showed small ero-
sions at the base of the distal phalanx (Fig. 1b). Mag-
netic resonance imaging for evaluation of their activi-
ties revealed enhancement at the base of the distal 
phalanx (Fig. 1c). Based on a diagnosis of ACH, the pa-
tient was treated with topical clobetasol propionate 
0.05% ointment and oral cyclosporin (5 mg/body 
weight kg/day) for several months, which improved 
the cutaneous manifestation, but not arthralgia. In 
addition, arthritis developed in his right elbow. Then, 
instead of corticosteroid and cyclosporin, we admin-
istered intravenous infliximab at a dose of 5 mg/kg on 
weeks 0, 2, and 6, and every 8 weeks, together with 
oral methotrexate 6 mg weekly. His arthralgia disap-
peared immediately, and the joint swelling and nail 
deformity gradually improved (Fig. 1d).
Case 2
A 55-year-old woman visited our hospital with 
polyarthralgia chiefly at the fingers, big toes, knees 
and ankles. Three months before the first visit, she 
had bilateral knee pain together with swelling. In a 
short time, painful swelling had also developed in the 
fingers and ankles, which was followed immediately 
by nail deformity of the bilateral big toes with swell-
ing and purulent discharge around the nails. Previ-
Figure 1. (a) Clinical features included edematous 
erythema on the acral parts of the fingers, pustules 
within the nail bed, and partial shedding of the nail 
plate; (b) bone x-ray image: arrows show bone ero-
sion; (c) magnetic resonance imaging: arrows show 
the enhancement; (d) clinical feature: improvement 
of skin manifestation after the administration of inf-
liximab and methotrexate.
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ously, reddish eruptions had not appeared except for 
acral regions. Examination showed yellowish-white 
discolored nails with atrophy in the bilateral big toes 
and erythema in the paronychial regions (Fig. 2a). Pu-
rulent discharge was seen from the subungual space 
and the surrounding erythema. Routine hematologic 
and immunologic examinations were normal except 
for an increase in antinuclear antibody, ×160. Fungal 
and bacterial cultures from the pustules and nails 
were negative. While bone x-rays showed no abnor-
malities, magnetic resonance imaging revealed sy-
novitis in the metatarsophalangeal joints of the left 
index and ring fingers (Fig. 2b). In addition, bone 
scintigraphy indicated increased uptakes in multiple 
joints (Fig. 2c). A biopsy from the toe skin showed 
elongation of rete ridges as well as dermal infiltra-
tion of neutrophils and lymphocytes, extending to 
the epidermis (Fig. 2d). The patient was treated with 
oral salazosulfapyridine 1000 mg daily as well as an 
occlusive dressing of tacrolimus ointment, which al-
leviated the cutaneous and joint symptoms (Fig. 2e). 
DISCUSSION
Acrodermatitis continua of Hallopeau usually devel-
ops on the distal portion of the digits with pustulation 
of the nail bed/matrix, which leads to onychodystrophy 
(1). We diagnosed these two cases as ACH, based on 
dystrophic nails surrounded by erythema with the his-
tory of relapsing periungual and subungual pustules as 
well as no eruptions except for acral regions.
Whereas arthritis is uncommon in ACH, these two 
cases showed polyarthritis chiefly distributed to the 
acral joints. However, its occurrence is not surprising 
because ACH is usually considered a variant of pustu-
lar psoriasis (2). Inflammation may extend from the 
nail folds and beds to the joints underneath. In addi-
tion, articular inflammation does not always localize 
to acral joints, as our two cases. The image findings 
in our case 1 were consistent with those of enthesitis. 
Enthesitis is a hallmark finding for psoriatic arthritis. 
The detection of enthesitis is facilitated by the use of 
magnetic resonance imaging and bone scintigraphy. 
They can evaluate not only the presence of enthesi-
tis, but also its activities, which are entheseal-related 
bone formations and erosions (4).
Therapeutic guidelines for ACH with arthritis do 
not seem to be established. ACH is frequently recalci-
trant to topical therapies using steroid, vitamin D3 or 
tacrolimus (5,6). In case 1, oral cyclosporin with topical 
Figure 2. (a) Clinical features: nail destruction with paronychial erythema on the bilateral big toes; (b) magnetic 
resonance imaging: arrows show synovitis in metatarsophalangeal joints; (c) bone scintigraphy showing mul-
tiple uptakes; asymmetric involvement of the distal and proximal interphalangeal joints; (d) histopathologic 
findings of erythema on the big toes: elongation of rete ridges with exocytosis of neutrophils and lymphocytes 
HE; x200; (e) clinical feature: improvement of skin manifestation after the administration of salazosulfapyridine 
with topical tacrolimus.
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steroid was effective for the skin lesions, but not for 
arthritis. Cyclosporin is usually not potently effective 
for arthralgia in psoriatic arthritis, and arthritis seems 
to be more refractory to conventional therapies than 
cutaneous manifestations (7). Based on the concept 
that ACH is a variant of pustular psoriasis, arthritis ac-
companied by ACH should be improved by therapies 
for psoriatic arthritis, including salazosulfapyridine, 
methotrexate and tumor necrosis factor- α (TNF-α) 
inhibitors (8). TNF-α inhibitors have been reported to 
provide satisfactory control of ACH (9). On the other 
hand, the clinical condition of ACH is occasionally re-
fractory to TNF- α inhibitors (10,11). In our case, intra-
venous infliximab combined with methotrexate was 
effective for arthritis and nail lesions in ACH. Based 
on the clinical manifestations including therapeutic 
responses, ACH with generalized arthritis would have 
similar pathological condition to psoriatic arthritis.
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